Literature DB >> 19373195

Wild poliovirus type 1 and type 3 importations--15 countries, Africa, 2008-2009.

.   

Abstract

The Global Polio Eradication Initiative began in 1988; by 2006, indigenous transmission of wild poliovirus (WPV) type 2 infection had been interrupted globally, and indigenous transmission of type 1 and 3 (WPV1 and WPV3) infection had been interrupted in all but four countries worldwide (Afghanistan, India, Nigeria, and Pakistan). Despite this success in controlling indigenous transmission, during 2002-2006, 20 previously polio-free countries in Africa and Asia had importations of WPV1 originating from Nigeria, and three polio-free countries in Africa had WPV1 importations originating from India. By the end of 2007, control efforts in all countries except Angola, Chad, Democratic Republic of the Congo (DRC), Niger, and Sudan had stopped transmission of WPV1 caused by these importations. However, during 2008-2009, multiple importations of WPV from countries with ongoing transmission resumed in Africa. This report describes 32 WPV importations into 15 African countries, resulting in 96 polio cases during January 2008-March 2009 and persistent WPV transmission in five previously polio-free African countries. As with the 2002-2006 resurgence, all of the importations originated from Nigeria or India, but more rapid WPV identification and response resulted in substantially fewer polio cases than reported during 2002-2006. Sensitive surveillance and continued rapid response supplemental immunization activities (SIAs) are key to limiting further WPV spread, interrupting the outbreaks, and allowing the polio prevention focus in Africa to return to eradicating polio in countries with persistent WPV transmission.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19373195

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  25 in total

1.  Detection of imported wild polioviruses and of vaccine-derived polioviruses by environmental surveillance in Egypt.

Authors:  Soile Blomqvist; Laila El Bassioni; Eman M El Maamoon Nasr; Anja Paananen; Svetlana Kaijalainen; Humayun Asghar; Esther de Gourville; Merja Roivainen
Journal:  Appl Environ Microbiol       Date:  2012-05-11       Impact factor: 4.792

2.  Lessons from polio eradication.

Authors:  Heidi J Larson; Isaac Ghinai
Journal:  Nature       Date:  2011-05-26       Impact factor: 49.962

3.  Phylogeny of imported and reestablished wild polioviruses in theDemocratic Republic of the Congo from 2006 to 2011.

Authors:  Nicksy Gumede; Jaume Jorba; Jagadish Deshpande; Mark Pallansch; Riziki Yogolelo; Jean Jacques Muyembe-Tamfum; Olen Kew; Marietjie Venter; Cara C Burns
Journal:  J Infect Dis       Date:  2014-11-01       Impact factor: 5.226

4.  Seroprevalence of antipolio antibodies among children <15 years of age in border provinces in China.

Authors:  HaiBo Wang; Hui Cui; ZhenGrong Ding; Pian Ba; ShuangLi Zhu; Ning Wen; LiXin Hao; Jing Ning; Jie Zhang; De Yang; WenBo Xu; Yong Zhang; ChunXiang Fan; WenZhou Yu; XiaoFeng Liang; HuiMing Luo
Journal:  Clin Vaccine Immunol       Date:  2013-05-15

5.  Supplementary polio immunization activities and prior use of routine immunization services in non-polio-endemic sub-Saharan Africa.

Authors:  Stephane Helleringer; Jemima A Frimpong; Jalaa Abdelwahab; Patrick Asuming; Hamadassalia Touré; John Koku Awoonor-Williams; Thomas Abachie; Flavia Guidetti
Journal:  Bull World Health Organ       Date:  2012-04-11       Impact factor: 9.408

6.  Multiple independent emergences of type 2 vaccine-derived polioviruses during a large outbreak in northern Nigeria.

Authors:  Cara C Burns; Jing Shaw; Jaume Jorba; David Bukbuk; Festus Adu; Nicksy Gumede; Muhammed Ali Pate; Emmanuel Ade Abanida; Alex Gasasira; Jane Iber; Qi Chen; Annelet Vincent; Paul Chenoweth; Elizabeth Henderson; Kathleen Wannemuehler; Asif Naeem; Rifqiyah Nur Umami; Yorihiro Nishimura; Hiroyuki Shimizu; Marycelin Baba; Adekunle Adeniji; A J Williams; David R Kilpatrick; M Steven Oberste; Steven G Wassilak; Oyewale Tomori; Mark A Pallansch; Olen Kew
Journal:  J Virol       Date:  2013-02-13       Impact factor: 5.103

Review 7.  Progress toward global interruption of wild poliovirus transmission, 2010-2013, and tackling the challenges to complete eradication.

Authors:  Steven G F Wassilak; M Steven Oberste; Rudolph H Tangermann; Ousmane M Diop; Hamid S Jafari; Gregory L Armstrong
Journal:  J Infect Dis       Date:  2014-11-01       Impact factor: 5.226

Review 8.  From emergence to eradication: the epidemiology of poliomyelitis deconstructed.

Authors:  Neal Nathanson; Olen M Kew
Journal:  Am J Epidemiol       Date:  2010-10-26       Impact factor: 4.897

9.  Outbreak of type 2 vaccine-derived poliovirus in Nigeria: emergence and widespread circulation in an underimmunized population.

Authors:  Steven Wassilak; Muhammad Ali Pate; Kathleen Wannemuehler; Julie Jenks; Cara Burns; Paul Chenoweth; Emmanuel Ade Abanida; Festus Adu; Marycelin Baba; Alex Gasasira; Jane Iber; Pascal Mkanda; A J Williams; Jing Shaw; Mark Pallansch; Olen Kew
Journal:  J Infect Dis       Date:  2011-04-01       Impact factor: 5.226

10.  A Multidisciplinary Research Agenda for Understanding Vaccine-Related Decisions.

Authors:  Heidi Larson; Julie Leask; Sian Aggett; Nick Sevdalis; Angus Thomson
Journal:  Vaccines (Basel)       Date:  2013-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.